Elizabeth Warren warns
agreement 'would tilt the playing field even more in favor of big multinational
corporations and against working families'
"The final text of the
agreement, released in November, is even worse than we imagined, with loopholes
in labor enforcement and rewards for outsourcing," writes AFL-CIO
president Richard Trumka. (Image: File)
With 12 nations expected to
sign the corporate-friendly Trans Pacific Partnership (TPP) in New Zealand on Thursday,
opponents in the U.S. and beyond are renewing their criticisms of the deal's
worst provisions, which they warn pose serious dangers to the climate, working
families, and democracy.
The signatures mark the end of
the negotiating process, with a broad agreement on the
deal having been reached
in October. Now, all 12 Pacific Rim countries will be able to begin their
respective domestic ratification processes, which in the U.S. means passage by
Congress.
"The TPP is a giveaway to
big corporations, special interests and all those who want economic rules that
benefit the wealthy few. It is no wonder the presidential front-runners from
both political parties oppose it."
—Richard Trumka, AFL-CIO
—Richard Trumka, AFL-CIO
Recent reporting
suggests Congress won't take up the issue until after the November
elections—which gives opponents time to hone their arguments against the toxic
deal.
"I urge my colleagues to
reject the TPP and stop an agreement that would tilt the playing field even
more in favor of big multinational corporations and against working
families," Sen. Elizabeth Warren (D-Mass.) said
on the U.S. Senate floor on Tuesday. Noting that "most of the TPP's 30
chapters don't even deal with traditional trade issues," she argued,
"most of TPP is about letting multinational corporations rig the rules on
everything from patent protection to food safety standards—all to benefit
themselves."
Warren was one of 38 senators
who voted
against a bill last year allowing the president to "Fast Track"
trade agreements like the TPP through Congress on a simple majority vote, with
senators unable to amend the deals or challenge specific provisions.
"A rigged process
produces a rigged outcome," she continued, blasting the composition of
advisory committees that were made up of industry executives and the cloak of
secrecy that surrounded the negotiations.
Warren specifically called out
the TPP's Investor-State Dispute Settlement, or ISDS, provisions, which she
said give "big companies...the right to challenge laws they don't like—not
in court, but in front of industry-friendly arbitration panels that sit outside
any court system. Workers, environmentalists, human rights advocates, they
don't get that special right—only corporations do."
Warren isn't the only one
sounding the alarm as the TPP snakes toward passage.
In a
statement on Tuesday, Alfred de Zayas, a U.N. independent expert on
democratic international order, decried the TPP as "fundamentally
flawed" and "based on an old model of trade agreements that is out of
step with today’s international human rights regime."
Highlighting widespread
opposition to the agreement, de Zayas added: "If a public referendum were
held in all twelve countries concerned, it will be solidly rejected."
And should the TPP eventually
be put into force, he concluded, "its compatibility with international law
should be challenged before the International Court of Justice."
Slamming the deal as "a
new low" and "a giveaway to Big Pharma" that would "take a
sledgehammer to American manufacturing," AFL-CIO president Richard Trumka
declared in an op-ed
published Tuesday:
The final text of the
agreement, released in November, is even worse than we imagined, with loopholes
in labor enforcement and rewards for outsourcing. Like its predecessor
agreements NAFTA and CAFTA, the TPP is a giveaway to big corporations, special
interests and all those who want economic rules that benefit the wealthy few.
It is no wonder the presidential front-runners from both political parties
oppose it.
[...] We’ve been down this
road before. The Wall Street and Washington elite always tell us that this time
will be different. The truth is these trade deals have ripped apart the fabric
of our nation. We see the shuttered factories. We visit towns that look like
they are stuck in the past. We talk to the workers who lost everything, only to
be told they should retrain in another field — but Congress has been slow to
fund and authorize those programs. From NAFTA to CAFTA to Korea and now the
TPP, these agreements have continually put profits over people. By driving down
our wages, they make our economy weaker, not stronger.
"If countries are serious
about addressing the climate crisis, they need to stand up to coal, oil and gas
companies, not reward them with new rights and privileges."
—Payal Parekh, 350.org
Meanwhile, climate group
350.org reiterated
on Wednesday how the TPP "would give dangerous new powers to the fossil
fuel industry."
"The TPP is a fossil fuel
industry handout," said Payal Parekh, 350.org global managing director.
"This partnership in pollution gives corporations the right to challenge
any local government or community that tries to keep fossil fuels in the
ground."
What's more, Parekh added, the
deal "makes a mockery of the climate agreement decided in Paris last
December. If countries are serious about addressing the climate crisis, they
need to stand up to coal, oil and gas companies, not reward them with new
rights and privileges."
While U.S. Trade
Representative Michael Froman told reporters on Tuesday that "momentum for
passage is growing," The Hill reports
Wednesday that with support waning among Congressional Republicans and Democrats
alike, TPP backers face an uphill climb on Capitol Hill.
According to The Hill,
AFL-CIO's Trumka and U.S. Rep. Rosa DeLauro (D-Conn.), both vocal opponents of
the agreement, are joining MoveOn in Washington, D.C. on Wednesday to deliver 1
million petitions calling on Congress to reject the agreement.
And on Thursday—World Cancer
Day—healthcare professionals and cancer patients will risk arrest outside the
headquarters of PhRMA, a trade association representing brand-name
pharmaceutical companies that pushed for expanded monopolies in the TPP, to
dramatize what they are calling the "TPP
Death Sentence."
h
No comments:
Post a Comment